These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8558505)

  • 41. The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis.
    Sugimoto H
    Chem Biol Interact; 2008 Sep; 175(1-3):204-8. PubMed ID: 18577377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
    Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
    J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method.
    Temiz-Arpaci O; Tekiner-Gulbas B; Yildiz I; Aki-Sener E; Yalcin I
    Bioorg Med Chem; 2005 Dec; 13(23):6354-9. PubMed ID: 15993083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis, and evaluation of benzophenone derivatives as novel acetylcholinesterase inhibitors.
    Belluti F; Piazzi L; Bisi A; Gobbi S; Bartolini M; Cavalli A; Valenti P; Rampa A
    Eur J Med Chem; 2009 Mar; 44(3):1341-8. PubMed ID: 18396354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ester derivatives of annulated tetrahydroazocines: a new class of selective acetylcholinesterase inhibitors.
    Carotti A; de Candia M; Catto M; Borisova TN; Varlamov AV; Méndez-Alvarez E; Soto-Otero R; Voskressensky LG; Altomare C
    Bioorg Med Chem; 2006 Nov; 14(21):7205-12. PubMed ID: 16843666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-Benzylpiperidine derivatives of 1,2,4-thiadiazolidinone as new acetylcholinesterase inhibitors.
    Martinez A; Fernandez E; Castro A; Conde S; Rodriguez-Franco I; Baños JE; Badia A
    Eur J Med Chem; 2000 Oct; 35(10):913-22. PubMed ID: 11121617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
    Kamath S; Buolamwini JK
    J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory mode of N-phenyl-4-pyrazolo[1,5-b] pyridazin-3-ylpyrimidin-2-amine series derivatives against GSK-3: molecular docking and 3D-QSAR analyses.
    Xiao J; Guo Z; Guo Y; Chu F; Sun P
    Protein Eng Des Sel; 2006 Feb; 19(2):47-54. PubMed ID: 16339768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives.
    Sugimoto H; Tsuchiya Y; Sugumi H; Higurashi K; Karibe N; Iimura Y; Sasaki A; Araki S; Yamanishi Y; Yamatsu K
    J Med Chem; 1992 Nov; 35(24):4542-8. PubMed ID: 1469686
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human acetylcholinesterase inhibitors: electronic-topological and neural network approaches to the structure-activity relationships study.
    Kandemirli F; Saraçoglu M; Kovalishyn V
    Mini Rev Med Chem; 2005 May; 5(5):479-87. PubMed ID: 15892689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA.
    Puntambekar DS; Giridhar R; Yadav MR
    Eur J Med Chem; 2006 Nov; 41(11):1279-92. PubMed ID: 16919851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues.
    Zhou X; Wang XB; Wang T; Kong LY
    Bioorg Med Chem; 2008 Sep; 16(17):8011-21. PubMed ID: 18701305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
    Arce MP; Rodríguez-Franco MI; González-Muñoz GC; Pérez C; López B; Villarroya M; López MG; García AG; Conde S
    J Med Chem; 2009 Nov; 52(22):7249-57. PubMed ID: 19856923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative molecular field analysis of quinoline derivatives as selective and noncompetitive mGluR1 antagonists.
    Sekhar YN; Nayana MR; Ravikumar M; Mahmood SK
    Chem Biol Drug Des; 2007 Dec; 70(6):511-9. PubMed ID: 18005334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists.
    Doddareddy MR; Cho YS; Koh HY; Pae AN
    Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis and biological evaluation of novel copper-chelating acetylcholinesterase inhibitors with pyridine and N-benzylpiperidine fragments.
    Zhou Y; Sun W; Peng J; Yan H; Zhang L; Liu X; Zuo Z
    Bioorg Chem; 2019 Dec; 93():103322. PubMed ID: 31585263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation.
    Niu C; Xu Y; Xu Y; Luo X; Duan W; Silman I; Sussman JL; Zhu W; Chen K; Shen J; Jiang H
    J Phys Chem B; 2005 Dec; 109(49):23730-8. PubMed ID: 16375354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
    Bolognesi ML; Andrisano V; Bartolini M; Banzi R; Melchiorre C
    J Med Chem; 2005 Jan; 48(1):24-7. PubMed ID: 15633997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives.
    Sugimoto H; Tsuchiya Y; Sugumi H; Higurashi K; Karibe N; Iimura Y; Sasaki A; Kawakami Y; Nakamura T; Araki S
    J Med Chem; 1990 Jul; 33(7):1880-7. PubMed ID: 2362265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.